Singh, A. and Singh, P. (2016) “TERIFLUNOMIDE: A NOVEL ORAL DISEASE-MODIFYING AGENT UNDER INVESTIGATION FOR THE TREATMENT OF MULTIPLE SCLEROSIS”, Journal of Drug Delivery and Therapeutics, 6(5), pp. 97–102. doi:10.22270/jddt.v6i5.1303.